RR Ellison
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Lymphoblastic Leukemia research 4
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- RS Weinberg (1 shared paper)C.J. Cornell (1 shared paper)James F. Holland (2 shared papers)Robert W. Carey (1 shared paper)Charles A. Schiffer (1 shared paper)B P Alter (1 shared paper)Lewis R. Silverman (1 shared paper)Roger B. Davis (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (1 paper)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
RR Ellison
6 papers receiving 324 citations
Peers
Comparison fields: 5 of 29
- Hematology 227
- Genetics 55
- Public Health, Environmental and Occupational Health 129
- Molecular Biology 148
- Oncology 38
Countries citing papers authored by RR Ellison
This map shows the geographic impact of RR Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RR Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RR Ellison more than expected).
Fields of papers citing papers by RR Ellison
This network shows the impact of papers produced by RR Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RR Ellison. The network helps show where RR Ellison may publish in the future.
Co-authors
The 25 scholars most cited alongside RR Ellison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. | 1993 | 169 |
| 2 | 1984 | 92 | |
| 3 | 1988 | 61 | |
| 4 | 1984 | 8 | |
| 5 | 1985 | 6 | |
| 6 | Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemia. | 1971 | 1 |
About RR Ellison
RR Ellison is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Genetics, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 6 papers that have together received 337 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (2 papers), Protein purification and stability (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Hematology (227 citations), Genetics (55 citations), Public Health, Environmental and Occupational Health (129 citations), Molecular Biology (148 citations) and Oncology (38 citations). RR Ellison has collaborated with scholars based in United States. Frequent co-authors include RS Weinberg, C.J. Cornell, James F. Holland, Robert W. Carey, Charles A. Schiffer, B P Alter, Lewis R. Silverman, Roger B. Davis, Janet Cuttner and RT Silver. Their work appears in journals such as Blood, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.